FDA Inspection 1234762 — EUGIA Pharma Specialities Limited
The FDA completed an inspection of EUGIA Pharma Specialities Limited on Nov 25, 2022 in Medchal-Malkajgiri District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Nov 25, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Medchal-Malkajgiri District (India)
Additional Details
Mutual Recognition Agreement (MRA)